http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2815240-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a785dc24227975c3da32ce1a909a89c |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9121 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfada54f948ffc280e216ef544ac7ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47eb7fabf384467dcae61003faf39a9 |
publicationDate | 2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2815240-A1 |
titleOfInvention | Use of the soluble form of axl in the diagnosis and/or prognosis of heart failure syndrome |
abstract | The present invention refers to a method for diagnosing and/or prognosing a heart failure syndrome (HF), which comprises the step of measuring, in vitro, the amount of the soluble form of AXL (sAXL) in a test sample. The invention furthermore provides methods for deciding or recommending whether to initiate a medical regimen, as well as for determining the efficacy of said medical regimen. The invention also provides the use of sAXL as a marker for the diagnosis and/or prognosis of HF sAXL is stable in serum and is differentially expressed in controls and people suffering from HF. |
priorityDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.